Online Only Articles

Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

Vancouver General Hospital, BC, Canada
Alexandra Hospital, Athens, Greece
University Hospital Tübingen, Germany
University Hospital Hotel-Dieu, Nantes, France
University Hospital and Health City of Science of Torino, Italy
University of Alberta, Edmonton, Canada
King’s College Hospital and King’s College London, UK
Erasmus Medical Center Rotterdam, The Netherlands
Celgene Corporation, Summit, NJ, USA
Celgene Corporation, Summit, NJ, USA
Adelphi Values, Boston, MA, USA
Celgene Corporation, Summit, NJ, USA
Celgene Corporation, Summit, NJ, USA
Celgene Corporation, Summit, NJ, USA
Hospital Universitario de Salamanca, Salamanca, Spain.
Vol. 100 No. 2 (2015): February, 2015 https://doi.org/10.3324/haematol.2014.112557